NINJ1 and cancer: While we were able to reproduce the finding that NINJ1 knockdown did not affect RSL3-induced ferroptosis, we found that NINJ1 knockdown robustly protected cancer cells against ferroptosis induced by xCT inhibitors, such as erastin and SAS.